Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria

Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria

<p><strong>Background</strong> Treatment of Plasmodium vivax malaria requires the clearing of asexual parasites, but relapse can be prevented only if dormant hypnozoites are cleared from the liver (a treatment termed “radical cure”). Tafenoquine is a single-dose 8-aminoquinoline th...

書目詳細資料
Main Authors:	Lacerda, MVG, Llanos-Cuentas, A, Krudsood, S, Lon, C, Saunders, DL, Mohammed, R, Yilma, D, Batista Pereira, D, Espino, FEJ, Mia, RZ, Chuquiyauri, R, Val, F, Casapía, M, Monteiro, WM, Brito, MAM, Costa, MRF, Buathong, N, Noedl, H, Diro, E, Getie, S, Wubie, KM, Abdissa, A, Zeynudin, A, Abebe, C, Tada, MS, Brand, F, Beck, H-P, Angus, B, Duparc, S, Kleim, J-P, Kellam, LM, Rousell, VM, Jones, SW, Hardaker, E, Mohamed, K, Clover, DD, Fletcher, K, Breton, JJ, Ugwuegbulam, CO, Green, JA, Koh, GCKW
格式:	Journal article
語言:	English
出版:	Massachusetts Medical Society 2019

相似書籍

Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria
由: Llanos-Cuentas, A, et al.
出版: (2019)

Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria
由: St Jean, PL, et al.
出版: (2020)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis
由: Watson, JA, et al.
出版: (2022)

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis'
由: Watson, JA, et al.
出版: (2024)

A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria.
由: Mark M Fukuda, et al.
出版: (2017-01-01)

Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review
由: Stephan Duparc, et al.
出版: (2020-03-01)

Hemolytic potential of tafenoquine in female volunteers heterozygous for glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PD Mahidol variant) versus G6PD-normal volunteers
由: Rueangweerayut, R, et al.
出版: (2017)

Tafenoquine — a radical improvement?
由: White, N
出版: (2019)

The antimalarial activity of tafenoquine in falciparum malaria
由: White, NJ
出版: (2023)

Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria
由: Raman Sharma, et al.
出版: (2024-05-01)

Tafenoquine for travelers' malaria: evidence, rationale and recommendations
由: Baird, J
出版: (2018)

Tafenoquine for the prevention of Plasmodium vivax malaria relapse
由: Watson, JA, et al.
出版: (2021)

Tafenoquine for children: a step towards implementation
由: Commons, RJ, et al.
出版: (2021)

Repurposing of the antimalarial agent tafenoquine to combat MRSA
由: Pengfei She, et al.
出版: (2023-12-01)

Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study
由: Geoffrey W. Birrell, et al.
出版: (2022-11-01)

Tafenoquine and G6PD: a primer for clinicians
由: Chu, CS, et al.
出版: (2019)

Tafenoquine versus primaquine to prevent relapse of plasmodium vivax malaria
由: Watson, J, et al.
出版: (2019)

Pharmacokinetic Models of Tafenoquine: Insights for Optimal Malaria Treatment Strategies
由: Luisa Oliveira Santos, et al.
出版: (2024-08-01)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
由: James A Watson, et al.
出版: (2022-12-01)

Single loading-dose tafenoquine for malaria chemoprophylaxis during brief travel?
由: Baird, JK
出版: (2021)

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
由: James A Watson, et al.
出版: (2024-02-01)

Determination of tafenoquine in dried blood spots and plasma using LC and fluorescence detection.
由: Römsing, S, et al.
出版: (2011)

Determination of tafenoquine in dried blood spots and plasma using LC and fluorescence detection
由: Romsing, S, et al.
出版: (2011)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
由: Watson, J, et al.
出版: (2018)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
由: James Watson, et al.
出版: (2018-04-01)

Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency
由: Commons, RJ, et al.
出版: (2020)

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
由: Ebstie YA, et al.
出版: (2016-07-01)

Relapses of Plasmodium vivax malaria threaten disease elimination: time to deploy tafenoquine in India?
由: Amit Sharma, et al.
出版: (2021-02-01)

Activities of artesunate-based combinations and tafenoquine against Babesia bovis in vitro and Babesia microti in vivo
由: Leonardo J. M. Carvalho, et al.
出版: (2020-07-01)

Extended blood stage sensitivity profiles of Plasmodium cynomolgi to doxycycline and tafenoquine, as a model for Plasmodium vivax
由: Christensen, Peter, et al.
出版: (2024)

Radical curative efficacy of tafenoquine combination regimens in <it>Plasmodium cynomolgi</it>-infected Rhesus monkeys (<it>Macaca mulatta</it>)
由: Kenworthy David, et al.
出版: (2011-07-01)

Interactions between tafenoquine and artemisinin-combination therapy partner drug in asexual and sexual stage Plasmodium falciparum
由: Karen Kemirembe, et al.
出版: (2017-08-01)

Enantiomeric resolution of primaquine, quinacrine and tafenoquine antibacterial medicines using ristocetin macrocyclic glycopeptide antibiotics CSP
由: Zeid A. ALOthman, et al.
出版: (2020-01-01)

Comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
由: Raman Sharma, et al.
出版: (2024-02-01)

Phytochemical Screening and Antimicrobial Activity Evaluation of Selected Medicinal Plants in Ethiopia
由: Dubale S, et al.
出版: (2023-02-01)

A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.
由: Hale, B, et al.
出版: (2003)

Efficacy Evaluation of 10-Hydroxy Chondrofoline and Tafenoquine against <i>Leishmania tropica</i> (HTD<sub>7</sub>)
由: Sayyed Ibrahim Shah, et al.
出版: (2022-08-01)

Failure of an Approximately Six Week Course of Tafenoquine to Completely Eradicate <i>Babesia microti</i> Infection in an Immunocompromised Patient
由: Prithiv J. Prasad, et al.
出版: (2022-09-01)

Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data
由: Hounkpatin AB, et al.
出版: (2019-03-01)

The blood schizonticidal activity of tafenoquine makes an essential contribution to its prophylactic efficacy in nonimmune subjects at the intended dose (200 mg)
由: Geoffrey Dow, et al.
出版: (2017-05-01)